Literature DB >> 26721243

The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma.

Eun Jung Lee1, Jeong Hoon Kim2, Eun Suk Park3, Shin Kwang Khang4, Young Hyun Cho1, Seok Ho Hong1, Chang Jin Kim1.   

Abstract

Because of the rarity of intracranial hemangiopericytomas (HPCs), the role of postoperative radiation therapy (PORT) in the management of HPC remains unclear. This study therefore analyzed the effects of PORT on patterns of failure and survival improvement in patients with HPC. Fifty-two patients surgically treated for intracranial HPC at our institution between 1992 and 2013 were retrospectively analyzed. Patterns of failure were subdivided into local recurrence, regional metastasis, and distant metastasis. Multivariate Cox proportional hazards models were used to assess factors prognostic of treatment failure and survival, and a time-dependent Cox proportional hazards models were used to investigate the correlations between patterns of failure and death. Of the 52 patients, 45 (87 %) underwent gross total resection, and 39 (75 %) received PORT. PORT significantly lengthened local control (LC) and overall survival (OS), by 14 and 13 months, respectively, independent of the extent of resection. Patients who did and did not receive PORT had 5 year LC rates of 97 and 44 %, respectively (HR .05, P = .002); and 10 year OS rates of 83 and 25 %, respectively (hazard ratio (HR) .20, P = .008). PORT, however, did not show preventive effects on regional and distant metastases. The main patterns of failure were local recurrence in patients who did not receive PORT and distant metastasis in those who received PORT. Regional metastasis was a main immediate cause of death (P < .001), and tended to occur more frequently and earlier in patients not receiving PORT.

Entities:  

Keywords:  Central nervous system; Hemangiopericytoma; Metastasis; Radiotherapy; Recurrence; Survival

Mesh:

Year:  2015        PMID: 26721243     DOI: 10.1007/s11060-015-2030-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices.

Authors:  V Vuorinen; P Sallinen; H Haapasalo; T Visakorpi; M Kallio; J Jääskeläinen
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Hemangiopericytoma: long-term outcome revisited. Clinical article.

Authors:  Marco Schiariti; Pablo Goetz; Hussien El-Maghraby; Jignesh Tailor; Neil Kitchen
Journal:  J Neurosurg       Date:  2010-07-30       Impact factor: 5.115

Review 3.  Predictors of mortality following treatment of intracranial hemangiopericytoma.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Derick Aranda; Steven A Mills; Igor J Barani; Andrew T Parsa
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

4.  Solitary fibrous tumor of the oral soft tissues: a clinicopathologic and immunohistochemical study of 16 cases.

Authors:  F Alawi; D Stratton; P D Freedman
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

5.  Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery.

Authors:  Claire Olson; Chun-Po Yen; David Schlesinger; Jason Sheehan
Journal:  J Neurosurg       Date:  2010-01       Impact factor: 5.115

6.  Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features.

Authors:  Sarah Barthelmeß; Helene Geddert; Carsten Boltze; Evgeny A Moskalev; Matthias Bieg; Horia Sirbu; Benedikt Brors; Stefan Wiemann; Arndt Hartmann; Abbas Agaimy; Florian Haller
Journal:  Am J Pathol       Date:  2014-02-08       Impact factor: 4.307

7.  Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients.

Authors:  Robert D Ecker; W Richard Marsh; Bruce E Pollock; Ozlem Kurtkaya-Yapicier; Robyn McClelland; Bernd W Scheithauer; Jan C Buckner
Journal:  J Neurosurg       Date:  2003-06       Impact factor: 5.115

8.  Meningeal hemangiopericytomas: long-term outcome and biological behavior.

Authors:  Jeong Hoon Kim; Hee-Won Jung; Yong-Su Kim; Chang Jin Kim; Sung-Kyun Hwang; Sun Ha Paek; Dong Gyu Kim; Byung Duk Kwun
Journal:  Surg Neurol       Date:  2003-01

9.  CD34 immunoreactivity in nervous system tumors.

Authors:  A Chaubal; A Paetau; P Zoltick; M Miettinen
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.

Authors:  Juliann Chmielecki; Aimee M Crago; Mara Rosenberg; Rachael O'Connor; Sarah R Walker; Lauren Ambrogio; Daniel Auclair; Aaron McKenna; Michael C Heinrich; David A Frank; Matthew Meyerson
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

View more
  6 in total

1.  Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.

Authors:  Connor J Kinslow; Raj S Rajpara; Cheng-Chia Wu; Samuel S Bruce; Peter D Canoll; Shih-Hsiu Wang; Adam M Sonabend; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Tony J C Wang
Journal:  J Neurooncol       Date:  2017-04-26       Impact factor: 4.130

2.  Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.

Authors:  Connor J Kinslow; Samuel S Bruce; Ali I Rae; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Adam M Sonabend; Tony J C Wang
Journal:  J Neurooncol       Date:  2018-02-09       Impact factor: 4.130

3.  Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma.

Authors:  Seung Hyuck Jeon; Sung-Hye Park; Jin Wook Kim; Chul-Kee Park; Sun Ha Paek; Il Han Kim
Journal:  J Neurooncol       Date:  2018-01-11       Impact factor: 4.130

4.  Intracranial solitary fibrous tumor/hemangiopericytoma: tumor reclassification and assessment of treatment outcome via the 2016 WHO classification.

Authors:  Dong-Won Shin; Jeong Hoon Kim; Sangjoon Chong; Sang Woo Song; Young-Hoon Kim; Young Hyun Cho; Seok Ho Hong; Soo Jeong Nam
Journal:  J Neurooncol       Date:  2021-08-20       Impact factor: 4.130

5.  The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11).

Authors:  Joo Ho Lee; Seung Hyuck Jeon; Chul-Kee Park; Sung-Hye Park; Hong In Yoon; Jong Hee Chang; Chang-Ok Suh; Su Jeong Kang; Do Hoon Lim; In Ah Kim; Jin Hee Kim; Jung Ho Im; Sung-Hwan Kim; Chan Woo Wee; Il Han Kim
Journal:  Cancer Res Treat       Date:  2021-03-24       Impact factor: 4.679

6.  The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor.

Authors:  Maria Paola Ciliberti; Rosa D'Agostino; Laura Gabrieli; Anna Nikolaou; Angela Sardaro
Journal:  Oncol Rev       Date:  2018-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.